BIO-TECHNE Corp vs Weibo Corp — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Weibo Corp trades at $8 (market cap $1.95B). The key difference: BIO-TECHNE Corp is far larger — about 5.7× Weibo Corp's market cap, and Weibo Corp pays the higher dividend (7.63%). Which is the better fit depends on your goals.
| TECH | WB | |
|---|---|---|
Market Cap | $11.16B | $1.95B |
Sector | Health | Media |
52-Week High | $72.12 | $12.83 |
52-Week Low | $43.31 | $7.20 |
Enterprise Value | $11.24B | $1.22B |
Dividend Yield | 0.45% | 7.63% |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →